Chen, R. C., Choueiri, T. K., Feuilly, M., Meng, J., Lister, J., Marteau, F., . . . Feldman, D. R. (2020). Quality‐adjusted survival with first‐line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance). Cancer.
استشهاد بنمط شيكاغوChen, Ronald C., et al. "Quality‐adjusted Survival With First‐line Cabozantinib or Sunitinib for Advanced Renal Cell Carcinoma in the CABOSUN Randomized Clinical Trial (Alliance)." Cancer 2020.
MLA استشهادChen, Ronald C., et al. "Quality‐adjusted Survival With First‐line Cabozantinib or Sunitinib for Advanced Renal Cell Carcinoma in the CABOSUN Randomized Clinical Trial (Alliance)." Cancer 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.